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Abstract
The aim of this study was to establish a comprehensive and yet parsimonious model of daily mobility activity in patients with 
neurological gait disorders. Patients (N = 240) with early-stage neurological (peripheral vestibular, cerebellar, hypokinetic, 
vascular or functional) gait disorders and healthy controls (N = 35) were clinically assessed with standardized scores related 
to functional mobility, balance confidence, quality of life, cognitive function, and fall history. Subsequently, daily mobil-
ity was recorded for 14 days by means of a body-worn inertial sensor  (ActivPAL®). Fourteen mobility measures derived 
from ActivPAL recordings were submitted to principle component analysis (PCA). Group differences within each factor 
obtained from PCA were analyzed and hierarchical regression analysis was performed to identify predictive characteristics 
from clinical assessment for each factor. PCA yielded five significant orthogonal factors (i.e., mobility domains) accounting 
for 92.3% of the total variance from inertial-sensor-recordings: ambulatory volume (38.7%), ambulatory pattern (22.3%), 
postural transitions (13.3%), sedentary volume (10.8%), and sedentary pattern (7.2%). Patients’ mobility performance only 
exhibited reduced scores in the ambulatory volume domain but near-to-normal scores in all remaining domains. Demographic 
characteristics, clinical scores, and fall history were differentially associated with each domain explaining 19.2–10.2% of their 
total variance. This study supports a low-dimensional five-domain model for daily mobility behavior in patients with neuro-
logical gait disorders that may facilitate monitoring the course of disease or therapeutic intervention effects in ecologically 
valid and clinically relevant contexts. Further studies are required to explore the determinants that may explain performance 
differences of patients within each of these domains and to examine the consequences of altered mobility behavior with 
respect to patients’ risk of falling and quality of life.
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Introduction
Disorders of gait and balance and associated mobility 
impairments are a common complication in neurological 
diseases and affect around 60% of patients [41]. Highest 
prevalence for gait and mobility impairments have been 
reported for patients with Parkinson’s disease, followed 
by vascular encephalopathy, cerebellar ataxia, and sensory 
deficits. Limitations in mobility function can be debilitat-
ing with considerable consequences for patients’ functional 
independence, social participation, and overall quality of life 
[24, 38]. Moreover, gait impairments in these patients are 
linked to an increased risk of falling [34, 42] and injuries 
resulting from falls not only entail substantial medical costs 
but also determine patients’ mortality risk [9].
Disease-specific clinical scales or outcomes from neuro-
logical functional diagnostics frequently fail to adequately 
reflect or predict the degree of mobility restrictions and the 
risk of falling in different neurological disease cohorts [7, 
10, 35]. It appears therefore crucial to directly and com-
prehensively examine gait and mobility function in these 
patients. In effect, functional mobility tests (e.g., the Timed 
Up and Go test [29]) and instrument-based measures of gait 
stability have been shown to more adequately capture mobil-
ity impairments and to more reliably identify a risk of falling 
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in central and peripheral neurological [28, 32, 33, 36, 37, 
45] as well as in geriatric patients [1, 13, 25]. However, a 
drawback of these approaches lies in the fact that they are 
primarily performed within the laboratory or a specialized 
clinical setting. They may therefore miss or underestimate 
the challenges of real-life mobility during which patients 
actually fall.
In this context, recent advances in daily mobility assess-
ment using body-worn inertial sensors promise a more 
adequate and specific characterization of patients’ mobility 
impairments in ecologically valid and clinically relevant set-
tings [20, 46]. In contrast to an instrument-based gait assess-
ment in the clinical setting, which focuses on the detailed 
spatiotemporal features of a patient’s gait pattern, body-worn 
sensors are primarily used to assess patients’ mobility from 
a macroscopic perspective [20]. Accordingly, sensor-based 
activity monitoring has been focused on measures that allow 
to quantify how single epochs (also referred to as ’bouts’ [3]) 
of activity (e.g., walking, standing, sitting, lying) alternate 
and accumulate over time. A plethora of such mobility meas-
ures have been proposed in the past (e.g., number of steps, 
intensity of activity, number and variability of activity bouts, 
etc. [4, 19, 31, 39]) and there is yet no consensus on what 
parameters best capture the essence of real-world mobility 
performance and are clinically most relevant.
Using techniques from factor analysis, Lord and col-
leagues could previously demonstrate that a large set of 
available mobility measures can be reduced to a meaning-
ful, small set of independent mobility domains that ade-
quately capture daily-life activity in community-dwelling 
older adults [19]. Based on this previous work, the aim of 
the present study was (1) to examine whether an analogous 
approach might yield a parsimonious and adequate model 
of daily mobility activity in patients with neurological gait 
disorders and (2) to explore which explanatory characteris-
tics might determine differences of patients’ mobility per-
formance within this model.
Methods
Participants
240 patients and 35 healthy controls were recruited as part 
of a cross-sectional prospective study. Inclusion criteria for 
patients were the presence of an early-stage, chronic gait 
disorder caused by either (1) a peripheral vestibular disorder 
(i.e., chronic or subacute vestibular dysfunction according 
to the diagnostic criteria [18, 43]; N = 66), (2) a cerebellar 
disorder (i.e., cerebellar ataxia according to the diagnostic 
criteria [6]; N = 72), (3) a hypokinetic disorder (i.e., the diag-
nosis of idiopathic Parkinson´s diseases, progressive supra-
nuclear palsy or multiple system atrophy according to the 
respective diagnostic criteria [15, 26]; N = 15), (4) a vascular 
disorder (i.e., white matter hyperintensities with cognitive 
and postural impairments according to the respective diag-
nostic criteria [2, 17]; N = 49), or (5) a functional disorder 
(i.e., functional vertigo and dizziness according to the diag-
nostic criteria [40]; N = 38). Further inclusion criteria were 
the ability to ambulate independently and the absence of any 
manifest motor weakness of the lower limbs (hemiparesis, 
paraparesis of the legs). Relatives of patients and employees 
at the hospital were recruited as healthy controls. All partici-
pants gave their informed written consent prior to inclusion.
Clinical assessment
All participants underwent a standardized interview, which 
included an inquiry of the following information: ambula-
tory status, functional status, medication. As part of a retro-
spective fall risk assessment, information on the number and 
the severity (based on the Hopkins grading scale [5]) of falls 
within the past 6 months was collected. Based on this infor-
mation, participants were categorized with respect to their 
fall status (non-faller; occasional faller; frequent faller, i.e., 
 Nfalls ≥ 2) and with respect to the most severe consequences 
of falling (no falling = grade 0; near falling = grade 1; falling 
without requiring medical attention = grade 2; falling requir-
ing medical attention = grade 3; falling requiring admission 
to the hospital = grade 4).
The subjective level of stability was evaluated by the Falls 
Efficacy Scale-International (FES-I) and the Activities-spe-
cific Balance Confidence scale (ABC-d) [12, 30]. Health-
related quality of life was assessed by the Short-Form Health 
Survey (SF-12) [8]. Cognitive function was screened with 
the Montreal Cognitive Assessment (MoCA) [27]. Each 
participant underwent a complete neurological and physical 
examination including the assessment of functional mobil-
ity by the Timed up Go test (TUG) and the Functional Gait 
Assessment score (FGA) [29, 44].
Daily mobility assessment
Monitoring of daily mobility was undertaken for 14 days. 
Participants wore an inertial-sensor-based activity monitor 
 (ActivPAL®, PAL Technologies, Glasgow), which recorded 
the sequence and period of time of individual bouts of ambu-
latory, sedentary, and sleeping behavior at a sample rate of 
10 Hz. The inertial sensor was placed at the thigh of the 
dominant leg approximately 0.1 m cranial and 0.05 m lateral 
of the patella. Participants were advised to continue their 
daily activities as usual and not to change their routine. At 
the end of the recording period, participants removed the 
sensor independently and sent it back via postal service.
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The following standard parameters (expressed as average 
daily estimates) were computed from the ActivPAL data in 
accordance to previously described procedures [19, 31] to 
represent characteristics of ambulatory, sedentary, and sleep-
ing behavior: intensity, i.e., the amount of energy expendi-
ture expressed as the total metabolic equivalents (METS); 
step count, i.e., the total number of steps; the number of 
sit-to-stance transitions (SST); the percentage of ambulatory, 
sedentary or sleeping time; the number and average dura-
tion of ambulatory and sedentary bouts; the distribution of 
ambulatory and sedentary bouts computed as the Gini Index, 
which characterizes how total time is accumulated from dif-
ferent bout lengths (a high Gini Index indicates a greater 
contribution of long bouts to the pattern of accumulation); 




A principle component analysis (PCA) was performed to 
identify which combinations of activity monitor measures 
best capture daily-life behavior. PCA is a factorization of 
the original m × n data matrix X ( n variables; m measure-
ments), such that
where W is an orthonormal projection matrix (i.e., WTW = I ) 
and P is the projection of original n-dimensional data matrix 
X onto the new r-dimensional space defined by W . Matrix W 
is referred to as the loading matrix and is computed so that 
its columns are the directions of maximum variance in the 
data, with the first column representing the direction of max-
imum variance, the second column the direction of the next 
largest variance and so forth. P is referred to as the factor 
score matrix. In total 14 variables (as described above) were 
included into PCA and varimax rotation was used to derive 
orthogonal factor scores, with the minimum eigenvalue for 
extraction set to 1. Items that met a minimum loading of 0.6 
were considered relevant [19, 21]. The obtained factor scores 
were used for further model evaluation.
Statistical analysis
Descriptive statistics are presented as mean ± SD. Analy-
sis of variance (ANOVA) and Chi-squared tests were used 
to test for differences of metric and categorial parameters 
from clinical assessment, daily mobility assessment, and 
retrospective fall assessment between patients and healthy 
controls. The obtained daily mobility domains from PCA 




ANOVA. Hierarchical regression analysis was performed 
to identify associations between each mobility domain and 
explanatory characteristics. Personal characteristics (age, 
gender, BMI) were entered first, followed by functional 
scores (FGA, TUG) in the second bock. The third block 
consisted of falls history (status, grade), and the fourth block 
included scores for balance confidence, activity level, qual-
ity of life, and cognitive function (FES-I, ABC-d, SF-12, 
MoCA). Standardized beta coefficients and partial correla-
tions were used to evaluate the contribution of each predictor 
to the variance within each mobility domain. Results were 
considered significant at p < 0.05. Statistical analysis was 
performed using SPSS (Version 25.0; IBM Corp., Armonk, 
NY, USA).
Results
Descriptive statistics on personal characteristics as well as 
outcomes from clinical assessment and daily mobility moni-
toring can be found in Table 1. Patients and healthy controls 
did not differ in basic demographics parameters. In accord-
ance to the recruitment criterion on preserved independent 
walking ability, patients exhibited only moderately impaired 
functional mobility scores in clinical assessment. They fur-
ther yielded near-to-normal cognitive function but reported 
lower confidence in balance and increased concerns about 
falling. In correspondence, retrospective fall assessment 
revealed that patients had considerably more often fallen 
in the past with significantly more severe consequences of 
falling (according to the Hopkins grading scale). Parameters 
from daily mobility monitoring in patients were predomi-
nantly within the normal range or only moderately impaired, 
in particular in terms of a reduced daily duration and inten-
sity of ambulatory behavior.
Out of the in total 14 included mobility measures, PCA 
yielded five orthogonal factors that did not exhibit notable 
cross-loadings. All item loadings were greater than 0.7 
(Table 2). The five obtained mobility domains account for 
92.3% of the total variance in activity monitor measures 
(Fig. 1a). We designate these domains as (1) ambulatory vol-
ume (i.e., the total amount of ambulatory activity; account-
ing for 38.7% of total variance), (2) ambulatory pattern (i.e., 
the temporal distribution and variability of different bouts 
of ambulatory activity; accounting for 22.3% of total vari-
ance), (3) postural transitions (accounting for 13.3% of total 
variance), (4) sedentary volume (i.e., the total amount of 
sedentary activity; accounting for 10.8% of total variance), 
and (5) sedentary pattern (i.e., the temporal distribution and 
variability of different bouts of sedentary activity; account-
ing for 7.2% of total variance). Daily mobility performance 
in patients and healthy controls was compared based on the 
five resultant daily mobility domains. This analysis revealed 
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that patients only showed reduced scores in the ambulatory 
volume domain but had near-to-normal scores in all remain-
ing domains. 
In a next step, associations between the obtained mobility 
domains and various explanatory characteristics were ana-
lyzed. For each mobility domain, we found differential mod-
erate associations with demographic items (age, gender), 
confidence (FES-I), and functional mobility (FGA, TUG) 
scores (Table 3). These characteristics explained between 
19.2% (for ambulatory volume) and 10.2% (for ambulatory 
pattern) of the total variance within domains. Falls grade 
(i.e., the most severe consequences of past fall events) and 
subjective fear of falling (i.e., FES-I) had the overall strong-
est impact on ambulatory volume. Functional mobility 
scores (i.e., FGA and TUG) were primarily associated with 
the two mobility domains related to sedentary behavior.
Discussion
Assessment of gait and mobility function is gaining increas-
ing importance for clinical diagnostics or monitoring of dis-
ease progression, as a measure for the efficacy of interven-
tions, and as a marker for identifying those patients at a high 
risk of falling. However, for gait as well as for daily mobility 
assessment, clinicians are often unable to decide, which of 
the plenty available outcome measures are the most appro-
priate for each of the above-mentioned applications [20]. In 
the past, factor analysis techniques have been successfully 
Table 1  Demographic, 
clinical, and daily mobility 
characteristics for patients 
(N = 240) and healthy controls 
(N = 35)
Significant group differences are highlighted in bold font
BMI body mass index, QoL quality of life, FES-I Falls Efficacy Scale-International, FGA Functional Gait 
Assessment score, TUG Timed Up and Go test, ABC-d Activities-specific Balance Confidence scale (ABC-
d), SF-12 Short-Form Health Survey, MoCA Montreal Cognitive Assessment, AB ambulatory bout, SB sed-
entary bout, SST sit-to-stance transitions
Characteristic Healthy subjects Patients ANOVA
Personal characteristics
 Age (years) 52.1 ± 17.7 54.3 ± 15.2 p = 0.424
 Gender (female/male) 19/16 122/118
 BMI 24.7 ± 3.9 27.0 ± 16.8 p = 0.425
Functional mobility scores
 FGA 27.7 ± 4.3 23.7 ± 5.5 p < 0.001
 TUG 8.7 ± 3.2 10.1 ± 4.9 p = 0.099
Fall status
 Status (no/occasional/frequent) 30/3/2 125/46/64 p = 0.001
 Grade (0/1/2/3/4) 26/4/3/2/0 66/60/69/21/19 p < 0.001
Confidence/QoL/cognitive scores
 FES-I 17.6 ± 2.7 27.4 ± 10.4 p < 0.001
 ABC-d 93.7 ± 11.8 70.2 ± 24.9 p < 0.001
 SF-12 30.3 ± 3.2 30.9 ± 3.1 p = 0.309
 MoCA 27.0 ± 2.8 24.8 ± 3.6 p = 0.001
Daily mobility measures
 Intensity (METS) 34.5 ± 1.3 33.7 ± 1.6 p = 0.004
 Step number 9424 ± 3291 7672 ± 3745 p = 0.009
 SST 40.3 ± 17.7 37.7 ± 15.4 p = 0.359
 Ambulatory percentage (%) 8.3 ± 2.8 6.8 ± 2.9 p = 0.006
 Sedentary percentage (%) 28.8 ± 7.4 30.8 ± 9.2 p = 0.238
 Sleep percentage (%) 39.4 ± 6.7 42.8 ± 9.9 p = 0.053
 AB number 461.5 ± 148.5 390.4 ± 148.4 p = 0.009
 SB number 45.3 ± 17.6 41.9 ± 15.4 p = 0.242
 AB duration (s) 15.9 ± 4.6 15.2 ± 4.0 p = 0.296
 SB duration (s) 618.2 ± 241.4 712.3 ± 365.2 p = 0.132
 AB distribution 0.61 ± 0.06 0.60 ± 0.07 p = 0.318
 SB distribution 0.70 ± 0.05 0.70 ± 0.05 p = 0.553
 AB variability 1.11 ± 0.09 1.09 ± 0.08 p = 0.191
 SB variability 1.57 ± 0.11 1.57 ± 0.13 p = 0.928
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applied to conceptualize both types of assessment, in 
terms of a low-dimensional set of independent functional 
domains (typically 3–5) that adequately cover the essential 
aspects of the general gait pattern at an microscopic and the 
everyday mobility performance at an macroscopic perspec-
tive [14, 19, 21, 45]. However, most of these conceptualiza-
tions and models were developed based on datasets derived 
from the healthy elderly population, which yet impedes a 
direct application to the clinical field of neurological gait 
and balance disorders.
Here we demonstrate that the approach of low-dimen-
sional modelling of real-world mobility behavior can be 
extended to patients with different forms of neurological 
gait disorders. Our obtained model includes five independ-
ent functional mobility domains, which we designate as 
ambulatory volume, ambulatory pattern, postural transitions, 
sedentary volume, and sedentary pattern. This model shares 
several communalities to the previously presented model 
from Lord and colleagues that was obtained from a dataset 
on community-dwelling older adults [19]. In particular, in 
both models, measures of ambulatory and sedentary activi-
ties as well as measures of transitions between these activi-
ties group in separate functional domains. Intuitively, quan-
tities of ambulatory and sedentary behavior should yield 
redundant information as they apparently represent opposing 
ends of the very same phenomenon. However, both models 
emphasize that the characterization of sedentary behavior 
and postural transitions between activities entails comple-
mentary information that is required to comprehensively 
capture the pattern of activities during daily-life routine. In 
contrast, to Lord’s model that is composed of only three 
domains (i.e., ambulatory behavior, sedentary behavior, 
and postural transitions), the current model comprises five 
functional domains inasmuch as ambulatory and sedentary 
activities are each further differentiated into a domain that 
reflects the volume and intensity of behavior and a domain 
that represents the distribution and regularity of behavior. 
This differentiation is in accordance with previous reports 
that indicate that both the volume and the diversity of activi-
ties reflect different aspects of the general mobility status of 
individuals [11, 22, 31]. Thus, the discrepancy between the 
two models presumably results from the apparently different 
ambulatory status of the two study populations. Accordingly, 
reduced activity levels in the elderly population in Lord’s 
study might eventuate in generally fewer degrees of freedom 
within the pattern of daily activities and a collapse of oth-
erwise functionally independent domains of behavior [16].
The current analysis focused on a patient cohort with 
an early-stage manifestation of different neurological 
gait impairments with yet retained independent ambula-
tory status (predominantly from a population at working 
age). This selection criterion was reflected in the obtained 
Table 2  Item loadings from principle component analysis for the five mobility domains
Relevant item loadings are highlighted in bold font
AB ambulatory bout, SB sedentary bout, SST sit-to-stance transitions
Item Ambulatory 
volume
Ambulatory pattern Postural transitions Sedentary volume Sedentary pattern
Ambulatory volume
 AB number 0.908 − 0.198 0.293 − 0.014 − 0.002
 Intensity 0.885 0.411 0.172 0.009 − 0.016
 Ambulatory percentage 0.879 0.382 0.221 0.012 − 0.039
 Step count 0.817 0.510 0.187 0.007 − 0.026
Ambulatory pattern
 AB duration 0.139 0.951 − 0.035 0.027 − 0.059
 AB variability 0.202 0.924 − 0.007 − 0.041 0.010
 AB distribution 0.102 0.908 − 0.041 − 0.073 0.058
Postural transitions
 SB number 0.176 − 0.011 0.937 0.245 − 0.037
 SST number 0.193 − 0.019 0.927 0.255 − 0.039
 SB duration − 0.501 0.000 − 0.708 0.325 − 0.008
Sedentary volume
 Sleep percentage − 0.357 0.092 − 0.177 − 0.842 − 0.040
 Sedentary percentage − 0.459 − 0.003 0.150 0.839 − 0.022
 Sedentary pattern
 SB distribution 0.080 − 0.044 0.104 − 0.103 0.947
 SB variability − 0.230 0.097 − 0.476 0.268 0.711
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model, according to which patients exhibited only mod-
erately reduced scores in the ambulatory volume domain 
compared to age-matched healthy participants but near-
to-normal scores in all remaining domains. Thus, patients 
in our cohort tended to maintain their everyday routine 
(i.e., a near-to-normal pattern of different activities 
over the day) despite showing initial signs of a disease-
related reduction on mobility volume. Regression analysis 
revealed that reduced performance in ambulatory volume 
domain was associated to a lower balance confidence and 
increased concerns about eventual falls. This association 
indicates that not only fall-related injuries that actually 
impair mobility function but already a lower balance con-
fidence resulting from an incipient decline of postural 
function and/or from former falls may considerably affect 
the amount of everyday mobility [19]. Moreover, higher 
scores of ambulatory volumes in patients were associated 
to more severe consequences of falling. In accordance with 
previous reports, this finding suggests that in particular for 
patients with early-stage gait disorders a longer exposure 
to walking situations entails a higher risk for the occur-
rence of frequent and especially of severe fall events [23].
Consistent with previous work, the overall outcome of 
regression analysis on mobility domains was only mod-
est [19]. Despite including a comprehensive set of demo-
graphic, subjective confidence, and clinical characteristics, 
we did not identify explanatory characteristics that would 
convincingly account for individual performance differ-
ences along the dimensions of the five different mobility 
domains. With respect to functional mobility scores (i.e., 
FGA and TUG), this observation indicates that real-world 
measures of mobility provide complementary information 
on patients’ mobility status that is not readily available 
from clinical evaluation. Counterintuitively, patients’ qual-
ity of life as assessed by the SF-12 score did not at all 
show any association to the different aspects of patients’ 
daily-life activity. This observation might at first glance 
contradict the high expectations on long-term mobility 
assessment as an specific and patient-relevant outcome 
measure for future clinical trials [46]. However, our focus 
on a clinical population with predominantly early-stage 
gait disorders that exhibited near-to-normal daily mobil-
ity performance and quality of life scores certainly lim-
its this observation. It is indeed conceivable that more 
pronounced impairments of daily mobility in advanced 
stages of neurological gait disorders may be actually more 
strongly associated to alterations in patients’ quality of 
life. Further studies that include a more comprehensive 
study population and more specific measures of health-
related quality of life are therefore required to corroborate 
or disprove this observation.
In conclusion, the here established model for daily 
mobility behavior in neurological gait disorders may pro-
vide a convenient framework for future studies on dis-
ease-specific mobility impairments and their consequences 
for patients’ well-being, quality of life, and risk of fall-
ing. The mainly negative results from regression analysis 
demand for further research to explore the characteris-
tics that may sufficiently explain performance differences 


































































Fig. 1  Relative importance of mobility domains and group differ-
ences within each domain. a Principle component analysis of the 
dataset with 14 mobility measures from 275 recordings yielded in 
total 14 components (black dots) with the five first factors (colored 
dots) explaining 92.3% of total variance (cumulative explained vari-
ance is indicated by gray dots). b Radar plot with median z values 
(colored dots) and interquartile ranges (gray shaded area) of patients 
for all five mobility domains. Patient data is normalized with respect 
to healthy control performance (dotted black line). Daily mobil-
ity activity in patients falls within the normal range for all domains 
except ambulatory volume
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